Loading...
Risk management in the treatment of type 2 diabetes with pioglitazone
INTRODUCTION: Type 2 diabetes mellitus is one of the most important cardiovascular risk factors. Insulin-resistance represents the common mechanism that leads to type 2 diabetes in obese subjects. Pioglitazone is an insulin-sensitizing agent available for treatment of type 2 diabetes. Large clinical...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3048017/ https://ncbi.nlm.nih.gov/pubmed/21437118 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|